Document Detail

Association of patient delay with symptoms, cardiac enzymes, and outcome in acute myocardial infarction.
MedLine Citation:
PMID:  2373099     Owner:  NLM     Status:  MEDLINE    
The delay between the onset of symptoms and the call for help is the longest single component of the time taken for patients with acute myocardial infarction to come under coronary care and receive thrombolytic therapy. In order to investigate factors influencing patient delay, visual analogue scores for pain, shortness of breath, and anxiety were obtained retrospectively from 250 patients with acute myocardial infarction, for the time of onset of symptoms, and for the time of the call for help. The predominant symptom was chest pain, followed by anxiety and breathlessness. Although all symptoms increased in severity after their onset, the initiation of a call was largely unexplained in terms of worsening symptoms. Patient delay had a skewed distribution with modal, median and mean values of up to 1 h, 1.5 h, and 11 h respectively. Patient delay was negatively correlated with the pain score at the time of calling, but most of the variance of patient delay could not be explained in terms of symptom scores. However, patient delay was independently and negatively related to maximum serum aspartate aminotransferase. During acute myocardial infarction, patients with higher cardiac enzyme levels experience more pain and delay less. This tendency for patients with more severe infarction and a greater risk of death to call for help sooner is an added reason for administering thrombolytic treatment at the first opportunity: those patients who call early have most to gain from prompt therapy.
J M Rawles; M J Metcalfe; C Shirreffs; K Jennings; A C Kenmure
Related Documents :
18301139 - Clinical findings of takotsubo cardiomyopathy: results from a multicenter international...
10945399 - Late cardiac arrhythmias after blunt chest trauma.
24140379 - Timing in resolution of left heart dilation according to the degree of mitral regurgita...
10540919 - Acute ischemic chest pain is not associated with increased calcitonin gene-related pept...
11899219 - Treatment of persistent chylothorax after norwood procedure with somatostatin.
19502619 - Safety of contrast flash-replenishment stress echocardiography in 500 patients with a c...
15717719 - Late ventricular potentials in risk assessment of the occurrence of complex ventricular...
19713689 - Images in gerontology: a case report.
9391229 - The physiologic cause of swallowing sounds: answers from heart sounds and vocal tract a...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European heart journal     Volume:  11     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1990 Jul 
Date Detail:
Created Date:  1990-08-30     Completed Date:  1990-08-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  643-8     Citation Subset:  IM    
Department of Medicine and Therapeutics, University of Aberdeen, Scotland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aspartate Aminotransferases / blood*
Middle Aged
Myocardial Infarction / diagnosis,  mortality,  physiopathology*
Pain Measurement
Patient Acceptance of Health Care*
Regression Analysis
Survival Analysis
Time Factors
Reg. No./Substance:
EC Aminotransferases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The significance of U wave polarity in patients with a prior anterior myocardial infarction.
Next Document:  Effects of diltiazem on postextrasystolic potentiation in coronary heart disease patients.